Gossamer Bio to present at Cantor Global Healthcare conference
Gossamer Bio, Inc. said it will present at the Cantor Global Healthcare Conference. The company is focused on seralutinib for pulmonary arterial hypertension (PAH) and PH-ILD.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.